Lexpos News

New research commissioned by Healthwatch England shows that public satisfaction with pharmacy services remains high a year after the NHS launched Pharmacy First, despite persistent medicine shortages that continue to disrupt patient care. In a poll of over 7,000 adults in England, 86% of those who sought help for common conditions reported a positive experience, [...]

The post Overwhelming public support for Pharmacy First service despite medicine supply issues appeared first on Community Pharmacy England.

The Drug Tariff Category M pricelist for July 2025 has been published on the NHS Business Services Authority (NHSBSA) website. Based on our analysis of the Category M price list for July 2025, Community Pharmacy England estimates there will be an overall reduction in reimbursement on like-for-like Category M medicines of approximately -£35m per quarter, [...]

The post July 2025 Category M prices announced appeared first on Community Pharmacy England.

Pharmacy owners should soon receive confirmation from NHSBSA that the 2025/26 CPAF screening questionnaire will be available for completion from 1st July 2025. As a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement of the Terms of Service. Therefore, pharmacy owners must complete the screening questionnaire and, [...]

The post 2025/26 Community Pharmacy Assurance Framework (CPAF) screening questionnaire appeared first on Community Pharmacy England.

Community Pharmacy England recently announced that consultation fees for the Hypertension Case-Finding Service (HCFS) and the Pharmacy Contraception Service (PCS) are to be included in the advance payments issued to pharmacy owners by the NHS Business Services Authority. The first service fee advance was received on 12 May (for activity completed in April 2025) and [...]

The post Service fee advances appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) Drug Alert Number: EL(25)A/31 Date issued: 30 June 2025 Wockhardt UK Limited is recalling the above batch as a precautionary measure following the identification of a dissolution failure during stability testing. DMRC reference number:DMRC-35980389 Marketing Authorisation Holder:Wockhardt UK Ltd Medicine Details Product name: Tamoxifen 20mg [...]

The post MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) appeared first on Community Pharmacy England.